SCYNEXIS Stock

SCYNEXIS Forward P/E

The Forward P/E Ratio of SCYNEXIS (SCYX) as of Jul 16, 2026 is -1.48. In the previous year, Forward P/E Ratio was 0.47 — a change of -414.92% (lower).

Forward P/E

-1.48

YoY

-414.92%

Last updated:

Forward P/E Ratio of SCYNEXIS is 2026 -1.48 . Forward P/E Ratio of SCYNEXIS was 2025 0.47 . It decreases by -414.92% lower compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Forward P/E Ratio of SCYNEXIS is -1.48 in 2026.

Access this data via the Eulerpool API

Valuation — SCYNEXIS

All Key Metrics — SCYNEXIS